175 related articles for article (PubMed ID: 16467405)
1. Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells.
Kiyomiya K; Lee MS; Tseng IC; Zuo H; Barndt RJ; Johnson MD; Dickson RB; Lin CY
Am J Physiol Cell Physiol; 2006 Jul; 291(1):C40-9. PubMed ID: 16467405
[TBL] [Abstract][Full Text] [Related]
2. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
[TBL] [Abstract][Full Text] [Related]
3. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease.
Oberst MD; Chen LY; Kiyomiya K; Williams CA; Lee MS; Johnson MD; Dickson RB; Lin CY
Am J Physiol Cell Physiol; 2005 Aug; 289(2):C462-70. PubMed ID: 15800053
[TBL] [Abstract][Full Text] [Related]
4. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.
Oberst M; Anders J; Xie B; Singh B; Ossandon M; Johnson M; Dickson RB; Lin CY
Am J Pathol; 2001 Apr; 158(4):1301-11. PubMed ID: 11290548
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells.
Lee MS; Kiyomiya K; Benaud C; Dickson RB; Lin CY
Am J Physiol Cell Physiol; 2005 Apr; 288(4):C932-41. PubMed ID: 15590895
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
[TBL] [Abstract][Full Text] [Related]
7. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.
Domoto T; Takino T; Guo L; Sato H
Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498
[TBL] [Abstract][Full Text] [Related]
9. Deregulated activation of matriptase in breast cancer cells.
Benaud CM; Oberst M; Dickson RB; Lin CY
Clin Exp Metastasis; 2002; 19(7):639-49. PubMed ID: 12498394
[TBL] [Abstract][Full Text] [Related]
10. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
[TBL] [Abstract][Full Text] [Related]
11. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK
Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
Parr C; Jiang WG
Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
[TBL] [Abstract][Full Text] [Related]
14. The hepatocyte growth factor regulatory factors in human breast cancer.
Parr C; Watkins G; Mansel RE; Jiang WG
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):202-11. PubMed ID: 14734471
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor.
Benaud C; Dickson RB; Lin CY
Eur J Biochem; 2001 Mar; 268(5):1439-47. PubMed ID: 11231297
[TBL] [Abstract][Full Text] [Related]
16. 3-Cl-AHPC inhibits pro-HGF maturation by inducing matriptase/HAI-1 complex formation.
Ye F; Chen S; Liu X; Ye X; Wang K; Zeng Z; Su Y; Zhang XK; Zhou H
J Cell Mol Med; 2019 Jan; 23(1):155-166. PubMed ID: 30370662
[TBL] [Abstract][Full Text] [Related]
17. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.
Wang JK; Lee MS; Tseng IC; Chou FP; Chen YW; Fulton A; Lee HS; Chen CJ; Johnson MD; Lin CY
Am J Physiol Cell Physiol; 2009 Aug; 297(2):C459-70. PubMed ID: 19535514
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin regulates matriptase activity involved in plasmin generation, syndecan shedding, and HGF activation in keratinocytes.
Chen YW; Xu Z; Baksh AN; Wang JK; Chen CY; Swanson R; Olson ST; Kataoka H; Johnson MD; Lin CY
PLoS One; 2013; 8(5):e62826. PubMed ID: 23675430
[TBL] [Abstract][Full Text] [Related]
20. Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract.
Zeng L; Cao J; Zhang X
World J Gastroenterol; 2005 Oct; 11(39):6202-7. PubMed ID: 16273651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]